Biogen Idec Foundation awards $1 million to Museum of Science to support stem education in Massachusetts
12 September 2012 | By Biogen Idec
The Biogen Idec Foundation has awarded the Museum of Science, Boston a $1 million grant...
List view / Grid view
News
AstraZeneca prices a $2 billion bond issue
12 September 2012 | By AstraZeneca
AstraZeneca PLC has conducted a successful global bond market transaction issuing a total of $2 billion of notes...
bioMérieux launches its VITEK® MS solution for automated, ultra rapid microorganism identification
11 September 2012 | By bioMérieux
VITEK® MS provides microorganism identification in minutes...
Five new grants to advance cancer nursing skills in Central and Eastern Europe
11 September 2012 | By Bristol-Myers Squibb Foundation
Recognizing the increasingly important role nurses play...
WHO grants expansion to the prequalification for Prevenar 13 to include adults 50+ years of age
11 September 2012 | By Pfizer
WHO has granted an expansion to the prequalification for Prevenar 13...
Summit enters technology license agreement with Bristol-Myers Squibb
11 September 2012 | By Peckwater PR
Summit has entered a technology license agreement with Bristol-Myers Squibb Company...
Sanofi Pasteur announces publication in The Lancet of world’s first efficacy results for its dengue vaccine candidate
11 September 2012 | By Sanofi Pasteur
“The complexity of dengue virus infection has hampered vaccine research for decades..."
Merck announces new Phase III data for suvorexant, an investigational insomnia medicine
10 September 2012 | By Merck
Merck remains on target to file a New Drug Application with the FDA in 2012...
Boehringer Ingelheim implements flexible fully disposable up- and downstream manufacturing
10 September 2012 | By Boehringer Ingelheim
Boehringer Ingelheim has developed and now implemented a flexible set-up...
Amgen names Ray Jordan Senior Vice President, Corporate Affairs
10 September 2012 | By Amgen
Amgen announced the appointment of Ray Jordan to the new position of senior vice president, Corporate Affairs...
Biogen Idec sells BENLYSTA royalty rights to DRI Capital managed fund
10 September 2012 | By Biogen Idec
Biogen Idec has sold to a DRI Capital managed fund its royalty and other rights relating to BENLYSTA®...
Lilly announces results from lung cancer study
6 September 2012 | By Eli Lilly and Company
The Phase III POINTBREAK trial did not meet its primary endpoint...
Boehringer Ingelheim and the ETH Zurich announce diabetes and obesity research collaboration
6 September 2012 | By Boehringer Ingelheim
The joint effort will focus on investigating three cell types...
Abbott to collaborate with Astellas in CMV Vaccine Trial
6 September 2012 | By Abbott
Abbott has signed an agreement to collaborate with Astellas Pharma Global Development...
New data for Novartis drug Lucentis® confirms long-term efficacy and safety profile and benefits of individualized treatment
5 September 2012 | By Novartis
New data for Lucentis®...
